Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Home > products > phospholipids
> phospholipid-peg-customization
> tumor-metastasis-targeting-peptide-peg-350-dspe
tumor metastasis targeting peptide-PEG350-DSPE
tumor metastasis targeting peptide-polyethylene-glycol-1,2-Distearoyl-sn-glycero-3-phosphoethanolamine
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-3477 | 50mg | 1350.00 | + Add to cart |
|
| R-C-3477 | 100mg | 2100.00 | + Add to cart |
|
|
|
||||
Product description
The target compound (tmt-peg-dspe) was prepared by coupling tumor metastasis targeting peptide(TMT)with lipid material(peg-dspe),which was used to construct targeted doxorubicin liposomes(tmt-ls-dox).tumor metastasis targeting modified nano carriers may be a new strategy to increase the specificity of chemotherapy drugs for high metastatic breast cancer.
| Appearance | N/A |
|---|---|
| PEG Molecular Weight | 350 |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 2 years |
Document
msds----tumor metastasis targeting peptide-PEG350-DSPE Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
